Liquidia Technologies Stock News & Updates
[WKN: A2JRNS | Symbol: LQDA]
Liquidia Technologies
Analysts' Top 5 Price Targets of March 06, 2026
Liquidia Technologies: The new Champion in the Billion-Dollar Pulmonary Hypertension Market
Through its unique PRINT platform, Liquidia manufactures highly precise inhaled medications that are...
Liquidia Technologies Gains Market Shares with YUTREPIA – Revenue Increases by 74% Quarter-over-Quarter!
Liquidia Technologies (LQDA) is successfully transforming from a purely development company into a commercial...
Buy Alert for Liquidia Corporation: With PRINT Technology and YUTREPIA, the niche market for rare lung diseases is set to be redefined!
The Liquidia Corporation (LQDA) is a biopharmaceutical company focused on the development and commercialization...
Tracking the Pivotal Point of Liquidia Technologies: After a Strong Rise, LifeSci Capital Sees Nearly 50% Upside Potential!
Liquidia Technologies impressed investors with a rapid market launch following the early approval of...
Analysts' Top 5 Price Targets of August 7, 2025
Liquidia Technologies [US53635D2027] LifeSci Capital confirms Buy rating with a price target...
Analysts' Top 5 Price Targets of May 27, 2025
Liquida Technologies [US53635D2027]: Bank of America reaffirms Buy rating and raises the price target...
Analysts' Top 5 Price Targets of May 5, 2025
Liquidia Technologies [US53635D2027]: Scotiabank reaffirms Buy rating and raises the price target from...
- ‹
- 1
- ›